| Name | Title | Contact Details |
|---|
MWI Veterinary Supply is a leading supply company for veterinarians in the United States.
Bayer MaterialScience is the global market leader in polyurethanes. The company develops and produces the components for rigid and flexible foams as well as for solid materials. Diverse applications range from mattresses and ski boots to insulating materials for refrigeration appliances and buildings. Bayer MaterialScience is also the leader in the development and production of polycarbonates. Lightweight, tough and freely formable, these high-performance plastics can be used in a wide variety of applications, including in the automotive and construction industries. Bayer MaterialScience is also one of the world’s leading suppliers of raw materials for coatings, adhesives and sealants. These products protect and enhance the appearance of such things as automobiles and furniture, and are used in the sports and leisure sector. In addition, Bayer MaterialScience supplies the chemical industry with numerous basic chemicals.
Alvita Care is a leading home care provider in New York City, Westchester, Long Island, and New Jersey. They provide in-home services that include home health aides and registered nurses. Their team works diligently to provide outstanding care.
Rome Health is a comprehensive healthcare system that delivers quality, compassionate medical care for every stage of life.
Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.